RELMADA THERAPEUTICS, INC. (RLMD) Insider Trading
Sector: Pharmaceuticals · Market Cap: $362M · 0 insider purchases in the last 7 days
No open market insider purchases at RELMADA THERAPEUTICS, INC. in the last 7 days.
Want more?
Sign up free to see 30+ days of history, set alerts, and track RLMD on your watchlist.
Start for FreeAbout RELMADA THERAPEUTICS, INC. Insider Trading
2 insiders at RELMADA THERAPEUTICS, INC. (RLMD) have purchased stock in the past 90 days, totaling $1.7M across 4 transactions (400,000 shares).
The most recent purchase was by CEO TRAVERSA SERGIO on September 10, 2026 — a $410K buy of 100,000 shares at $4.10, bringing his total holdings to 1,500,000 shares.
Insiders who purchased: Shenouda Maged (CFO, 2 buys totaling $844K); TRAVERSA SERGIO (CEO, 2 buys totaling $828K).
RLMD is in the Pharmaceuticals sector within the Pharmaceuticals industry with a market cap of $362M.
Track RLMD insider trading activity, set up email alerts, and get AI-powered trade analysis with a free Insider Trading Tracker account.